Doctors at AGMC and GBP Hospital have prepared a treatment plan for Manashree Chowdhury, a 22-month-old child with Spinal Muscular Atrophy. Expert consultation from AIIMS New Delhi has been planned as Tripura’s crowdfunding campaign continues to support her advanced medical treatment.
The Department of Neurology at AGMC and GBP Hospital in Agartala has prepared a comprehensive treatment plan for 22-month-old Manashree Chowdhury, who has been diagnosed with Spinal Muscular Atrophy (SMA), a rare and life-threatening genetic disorder. The medical team has decided to seek expert guidance from the Child Neurology Department at AIIMS, New Delhi, to ensure the child receives the most appropriate and advanced treatment.
Addressing the media on Monday, neurologist Dr. Abir Lal Nath said that after conducting a detailed medical evaluation, the doctors unanimously agreed that an expert opinion from AIIMS would be the next crucial step in Manashree’s treatment journey. The consultation aims to determine the most suitable course of action based on the child’s medical condition and the latest treatment protocols available for SMA.
Manashree, accompanied by her parents, recently visited the Neurology Department at AGMC and GBP Hospital, where she underwent an extensive examination by a team of specialists that included Dr. Abir Lal Nath, Dr. Arpan Mitra, and Dr. Supriya Jamatia. Following the assessment, the doctors prepared a preliminary treatment strategy while considering the complexities associated with the rare neuromuscular disorder.
Deputy Medical Superintendent of AGMC and GBP Hospital, Dr. Kanak Choudhury, also visited the department during the consultation process and held discussions with the medical team regarding the proposed treatment plan. Hospital authorities have emphasized that every effort is being made to ensure Manashree receives comprehensive medical attention.
To provide a multidisciplinary approach, opinions were sought from specialists representing several departments. These included Neurosurgery specialist Dr. Reddy, Professor Dr. Sanjeeb Debbarma from the Department of Pediatrics, and experts from the Department of Physical Medicine and Rehabilitation (PMR). The collaborative discussions were later reviewed in detail with Prof. (Dr.) Tapan Majumdar.
Following extensive deliberations, the medical team decided to refer the case to Professor and Head of the Department of Child Neurology at AIIMS, New Delhi, Dr. Shefali Gulati, for an expert consultation. The doctors stated that the future treatment plan would be finalised based on Dr. Gulati’s recommendations and expert assessment.
Dr. Nath assured that the team at AGMC and GBP Hospital will remain actively involved throughout Manashree’s treatment. He said the doctors would closely monitor every stage of her medical care and extend all possible support to help the child recover and lead a healthy life. He also appealed to the public to keep Manashree in their prayers and wish her a speedy recovery.
Meanwhile, public support for Manashree has continued to grow across Tripura and beyond. An unprecedented crowdfunding campaign has united citizens, social organisations, volunteers, and well-wishers in an effort to raise funds for her advanced treatment. According to available estimates, the treatment required for Spinal Muscular Atrophy could cost nearly Rs. 18 crore, making financial assistance crucial for the family.
| Also Read: Tripura Rallies Behind Manashree as CM, MP Extend Support for Critical Treatment |
Appeals seeking donations have been widely circulated through social media platforms, community organisations, and volunteer networks. The campaign has witnessed overwhelming participation, reflecting the collective compassion of people determined to help Manashree access the specialised treatment she urgently needs. As preparations continue for expert consultation at AIIMS, the combined efforts of the medical community and the public have offered renewed hope for the young child’s fight against the rare disease.
